From USFDA
Natco Pharma has received successful Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for the inspection conducted, during the period 08 February - 12 February 2016, at its Chemical Division, Chennai, India (named NATCO Organics, prior to amalgamation into the company).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
